Business Context and Reporting Period
This Form 8-K filing by Humacyte, Inc. (HUMA) was submitted on May 4, 2026. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's continued listing status.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate governance and listing compliance matter.
Material Changes
The material event reported is the receipt of a Nasdaq notification stating that the company's common stock bid price closed below the minimum $1.00 per share requirement for 30 consecutive business days ended May 1, 2026. This triggers a compliance period under Nasdaq Listing Rule 5810(c)(3)(A).
Outlook, Risks, and Management Commentary
- Compliance Period: The company has been granted an initial 180 calendar days, until November 2, 2026, to regain compliance.
- Requirement: To maintain listing, the closing bid price must be $1.00 or more for a minimum of 10 consecutive business days before the November 2, 2026 deadline.
- Current Status: The notice has no immediate effect on the listing; the stock continues to trade on The Nasdaq Global Select Market.
- Management Action: The company intends to monitor the bid price and consider available options to achieve compliance.
- Risks: There is no assurance that the company will regain compliance. Failure to do so could result in delisting. The filing includes standard forward-looking statement disclaimers regarding the uncertainty of meeting these requirements.
Investor Verification Checklist
- Verify the current trading price of HUMA relative to the $1.00 threshold.
- Monitor the stock's performance over the next 10 consecutive business days to assess immediate compliance progress.
- Review the company's 2025 Form 10-K for detailed risk factors related to liquidity and capital resources.
- Watch for future announcements regarding potential capital raising activities or reverse stock splits as potential compliance strategies.